宏柏新材(605366) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 377,270,519.57, representing an increase of 18.02% compared to the same period last year[3]. - The net profit attributable to shareholders for Q1 2024 was CNY 7,075,145.30, a significant increase of 71.95% year-on-year[3]. - The company reported a decrease in net profit after deducting non-recurring gains and losses by 24.49% to CNY 2,650,677.30[3]. - The net profit for Q1 2024 was CNY 7,075,145.30, a significant increase of 72.5% compared to CNY 4,114,654.03 in Q1 2023[21]. - The total comprehensive income for Q1 2024 was CNY 7,019,512.35, compared to CNY 4,540,964.46 in Q1 2023, marking a growth of 54.5%[21]. Cash Flow - The net cash flow from operating activities was negative at CNY -33,187,381.29, a decrease of 259.12% compared to the previous year[3]. - The company reported a net cash outflow from operating activities of CNY -33,187,381.29, compared to a positive cash flow of CNY 20,856,757.62 in Q1 2023[24]. - Cash and cash equivalents at the end of Q1 2024 totaled CNY 240,752,855.78, down from CNY 359,656,687.22 at the end of Q1 2023[25]. - The cash flow from operating activities was CNY 290,682,526.89 in Q1 2024, compared to CNY 235,276,168.76 in Q1 2023[33]. - The company received $6,713,507.61 in cash related to operating activities, a notable increase from $2,372,930.59, indicating improved cash collection[34]. Assets and Liabilities - Total assets at the end of Q1 2024 amounted to CNY 3,086,397,016.34, reflecting a growth of 2.89% from the end of the previous year[4]. - Total assets as of March 31, 2024, were RMB 3,086,397,016.34, compared to RMB 2,999,633,547.52 at the end of 2023, indicating a growth of 2.91%[16]. - Total liabilities increased to RMB 1,088,179,705.97 from RMB 1,010,920,068.06, marking a rise of 7.63%[16]. - The total liabilities increased to CNY 1,197,321,364.25 in Q1 2024, compared to CNY 1,124,895,286.06 in Q4 2023[28]. - The company's total equity as of March 31, 2024, was CNY 1,923,384,997.90, slightly up from CNY 1,911,528,710.10 at the end of 2023[29]. Shareholder Information - The top shareholder, Hongbai Chemical Co., Ltd., holds 22.48% of the shares, with a total of 137,646,667 shares[10]. - The equity attributable to shareholders increased slightly by 0.48% to CNY 1,998,217,310.37 compared to the end of the previous year[4]. Operating Costs and Expenses - Total operating costs rose to CNY 376,898,102.18, up from CNY 308,559,079.30, reflecting an increase of 22.1% year-over-year[20]. - Research and development expenses increased to CNY 10,057,800.30, a rise of 32.6% from CNY 7,581,376.95 in the previous year[20]. - The company's R&D expenses for Q1 2024 were CNY 9,883,772.82, an increase of 30.4% from CNY 7,581,376.95 in Q1 2023[30]. - The company incurred a financial expense of CNY 4,193,453.14, down from CNY 7,380,390.82 in the previous year, indicating a reduction of 43.5%[20]. Government Support - The company received government subsidies amounting to CNY 5,008,180.62, contributing positively to the net profit[5]. Strategic Initiatives - The company is actively exploring new strategies for market expansion and product development, although specific details were not disclosed in the report[3].